EPCAM and hepatocellular carcinoma: Moreover, the number of surviving CSLCs in DOX and WM130-cotreated mice was even lower, which was consistent with our in vitro finding that WM130 suppressed DOX-resistant HCC cells, especially EpCAM+ cells.